I undersøgelsen af patienter med fremskreden Parkinsons sygdom var der større bedring hos de patienter, der fik 24 ugers behandling med Sifrol i fast dosering, end hos dem, der fik placebo.
In the study of patients with advanced Parkinson’ s disease, patients taking Sifrol had larger improvements after 24 weeks of steady-dose treatment than those taking placebo.